Rubedo Life Sciences

Rubedo.Life

This company develops small-molecule prodrugs that selectively eliminate senescent cells for patients with age-related chronic diseases and skin conditions.

Rubedo

This biopharmaceutical company develops therapeutics targeting senescent cells to treat chronic age-related diseases for patients with skin and pulmonary conditions.

Rejuveron Life Sciences

This clinical-stage biotechnology company develops regenerative medicines and small-molecule therapies for patients with age-related diseases to improve healthspan and longevity.

Cible Skin

This company develops and sells science-based skincare products and clinical treatments for consumers seeking anti-ageing and cell regeneration solutions.

Senisca

This company develops oligonucleotide-based therapeutics that reprogramme senescent cells to treat age-related diseases and aesthetic signs of ageing for patients and pharmaceutical partners.

Integrated Biosciences

The company develops small-molecule therapies for age-related diseases using a synthetic biology and machine learning platform to target cellular stress responses.

Centenara Labs

This company develops and invests in therapeutics targeting age-related diseases for patients needing extended healthspan and improved lifespan.

Deciduous Therapeutics

This company develops small-molecule immunotherapies that activate the immune system to remove senescent cells for patients with age-related, metabolic and fibrotic diseases.